[go: up one dir, main page]

PE20011042A1 - Uso de glutamina para la prevencion de diarrea de inicio tardio inducida por irinotecan - Google Patents

Uso de glutamina para la prevencion de diarrea de inicio tardio inducida por irinotecan

Info

Publication number
PE20011042A1
PE20011042A1 PE2001000027A PE2001000027A PE20011042A1 PE 20011042 A1 PE20011042 A1 PE 20011042A1 PE 2001000027 A PE2001000027 A PE 2001000027A PE 2001000027 A PE2001000027 A PE 2001000027A PE 20011042 A1 PE20011042 A1 PE 20011042A1
Authority
PE
Peru
Prior art keywords
irinotecan
glutamine
late onset
prevention
day
Prior art date
Application number
PE2001000027A
Other languages
English (en)
Spanish (es)
Inventor
Diane Savarese
Original Assignee
Univ Massachusetts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Massachusetts filed Critical Univ Massachusetts
Publication of PE20011042A1 publication Critical patent/PE20011042A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PE2001000027A 2000-01-18 2001-01-12 Uso de glutamina para la prevencion de diarrea de inicio tardio inducida por irinotecan PE20011042A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48496200A 2000-01-18 2000-01-18

Publications (1)

Publication Number Publication Date
PE20011042A1 true PE20011042A1 (es) 2001-09-26

Family

ID=23926357

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000027A PE20011042A1 (es) 2000-01-18 2001-01-12 Uso de glutamina para la prevencion de diarrea de inicio tardio inducida por irinotecan

Country Status (4)

Country Link
AU (1) AU2001229478A1 (fr)
CO (1) CO5280204A1 (fr)
PE (1) PE20011042A1 (fr)
WO (1) WO2001052828A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2295429A1 (fr) * 2000-01-06 2001-07-06 Michael Michael Traitement ou prevention de la diarrhee
WO2004103371A1 (fr) * 2003-05-21 2004-12-02 Pharmacia & Upjohn Company Llc Utilisation d'inhibiteurs de cftr dans le traitement de la diarrhee induite par la chimiotherapie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786344A (en) * 1994-07-05 1998-07-28 Arch Development Corporation Camptothecin drug combinations and methods with reduced side effects
US5646159A (en) * 1994-07-20 1997-07-08 Research Triangle Institute Water-soluble esters of camptothecin compounds

Also Published As

Publication number Publication date
WO2001052828A3 (fr) 2002-04-18
AU2001229478A1 (en) 2001-07-31
WO2001052828A2 (fr) 2001-07-26
CO5280204A1 (es) 2003-05-30

Similar Documents

Publication Publication Date Title
DK0954314T3 (da) Doseringsformer til bedring af mandlig erektionsdefekt
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
EA200700049A1 (ru) Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
BRPI0108977B8 (pt) compostos azacíclicos, composição farmacêutica e uso de um composto ou sal farmaceuticamente aceitável do mesmo
WO2005065069A3 (fr) Procedes pharmaceutiques, posologies et formes posologiques pour le traitement de la maladie d'alzheimer
BR0015188A (pt) Composições farmacêuticas
SG157406A1 (en) Oral medicament for the modified release of at least one active principle, in multi-microcapsule form
GEP20053473B (en) High Potency Dihydroergotamine Compositions
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
MY118164A (en) Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia
YU49026B (sh) UPOTREBA 17 Гџ -(N-TERC-BUTILKARBAMOIL)-4-AZA-5-ALFA-ANDROST-1-3-ON ZA PROIZVODNJU LEKA ZA TRETIRANJE ANDROGENE ALOPECIJE
DK0680326T3 (da) Farmaceutisk formulering af nikotinafhængighed.
BR0211198A (pt) Composições farmacêuticas e seu uso
ES2168241T1 (es) Preparacion farmaceutica que contiene tolperisona para administrar por via oral.
AP2003002763A0 (en) Controlled release formulations for oral administration
MY141012A (en) Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
YU36401A (sh) Farmaceutska kompozicija za stimulator osetljivosti na insulin sa modifikovanim ispuštanjem
MXPA02012730A (es) Uso de acido pamoico o uno de sus derivados o uno de sus analogos para la preparacion de un medicamento para el tratamiento de enfermedades caracterizadas por depositos de agregados de amiloide.
ATE311928T1 (de) (-)-pseudoephedrin als sympathomimetisches arzneimittel
DE59914183D1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
PE20011042A1 (es) Uso de glutamina para la prevencion de diarrea de inicio tardio inducida por irinotecan
GEP20043377B (en) Pharmaceutical Complex
AR014082A1 (es) Concentrado oral de sertralina
SE0000303D0 (sv) Novel compounds
ATE47664T1 (de) Pharmazeutische dosierungseinheit.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal